Back to PCRX
D. E. Shaw & Co., Inc. PCRX Position History
Pacira BioSciences, Inc. • Healthcare
Quarters held
19
Latest value
$1.1M
Q2 2026
Peak value
$52.7M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $7M |
| Q1 2024 | $7M |
| Q2 2024 | $13.7M |
| Q3 2024 | $27.9M |
| Q3 2024 | $1.5M |
| Q4 2024 | $39.8M |
| Q4 2024 | $2.7M |
| Q1 2025 | $52.7M |
| Q1 2025 | $3.5M |
| Q2 2025 | $51.3M |
| Q2 2025 | $2.6M |
| Q3 2025 | $48.8M |
| Q3 2025 | $1.2M |
| Q4 2025 | $51.5M |
| Q4 2025 | $1.3M |
| Q1 2026 | $43.8M |
| Q1 2026 | $1M |
| Q2 2026 | $48.4M |
| Q2 2026 | $1.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.1M | 42.8K | — | — |
| Q2 2026 | $48.4M | 1.91M | — | — |
| Q1 2026 | $1M | 46.3K | — | — |
| Q1 2026 | $43.8M | 1.94M | — | — |
| Q4 2025 | $1.3M | 50.1K | — | — |
| Q4 2025 | $51.5M | 1.99M | — | — |
| Q3 2025 | $1.2M | 47.4K | — | — |
| Q3 2025 | $48.8M | 1.89M | — | — |
| Q2 2025 | $2.6M | 107.9K | — | — |
| Q2 2025 | $51.3M | 2.15M | — | — |
| Q1 2025 | $3.5M | 142.3K | — | — |
| Q1 2025 | $52.7M | 2.12M | — | — |
| Q4 2024 | $2.7M | 145.0K | — | — |
| Q4 2024 | $39.8M | 2.11M | — | — |
| Q3 2024 | $1.5M | 102.8K | — | — |
| Q3 2024 | $27.9M | 1.85M | — | — |
| Q2 2024 | $13.7M | 480.4K | — | — |
| Q1 2024 | $7M | 240.4K | — | — |
| Q4 2023 | $7M | 206.0K | — | — |